Ray Dalio's SNY Position Overview
Ray Dalio (via Bridgewater Associates, Lp) currently holds 206,873 shares of Sanofi (SNY) worth $8.83 M, representing 0.04% of the portfolio. First purchased in 2026-Q2, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Ray Dalio has initiated a new position in SNY, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Ray Dalio's Sanofi (SNY) Holding Value Over Time
Track share changes against reported price movement
Quarterly Sanofi (SNY) Trades by Ray Dalio
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +206,873 | New Buy | 206,873 | $42.66 |
Ray Dalio's Sanofi Investment FAQs
Ray Dalio first purchased Sanofi (SNY) in Q2 2026, acquiring 206,873 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio has held Sanofi (SNY) for 1 quarters since Q2 2026.
Ray Dalio's largest addition to Sanofi (SNY) was in Q2 2026, adding 206,873 shares worth $8.83 M.
According to the latest 13F filing for Q2 2026, Ray Dalio's firm, Bridgewater Associates, Lp, owns 206,873 shares of Sanofi (SNY), valued at approximately $8.83 M.
As of the Q2 2026 filing, Sanofi (SNY) represents approximately 0.04% of Ray Dalio's publicly disclosed stock portfolio, making it one of their key holdings.
Ray Dalio's peak holding in Sanofi (SNY) was 206,873 shares, as reported at the end of Q2 2026.